MOH SEC filings (2026)
CIK 1179929 · Hospital & Medical Service Plans (SIC 6324) · incorporated in DE · fiscal year ends in December
2,674 filings on EDGAR since 2002 · 24 annual, 72 quarterly, 438 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
July 2026
June 2026
- Jun 108-K8-K · Molina Healthcare Wins Illinois Medicaid ContractRegulation FD disclosure
May 2026
- May 14Insider saleHEBERT MAURICE (Chief Accounting Officer) sold 600 shares for $115K at $191.55
- May 11Insider saleBarlow Jeff D. (Chief Legal Officer) sold 17,811 shares for $3.3M at $186.12
- May 118-K8-K · Directors or officers; compensation; Charter, bylaws or fiscal-year change; Shareholder vote results
- May 88-K8-K · Regulation FD disclosure
April 2026
March 2026
- Mar 23ProxyProxy · Annual report to shareholders
- Mar 23ProxyProxy · Additional proxy materials
- Mar 23ProxyProxy · Proxy statement
- Mar 13ProxyProxy · Preliminary proxy statement
- Mar 12Insider saleROMNEY RONNA (Director) sold 506 shares for $74K at $146.92
February 2026
- Feb 268-K8-K · Regulation FD disclosure
- Feb 11Insider buyZORETIC RICHARD C (Director) bought 800 shares for $100K at $125.16
- Feb 10ReportAnnual report, FY2025 — revenue $45.43B (+12% y/y), net income $472.0M, EPS $8.92
- Feb 68-K8-K · Material definitive agreement; New financial obligation; Material impairment
- Feb 5EarningsEarnings release — EPS −$2.75 vs $0.43 est. (−739.5%); revenue $11.38B (+8% y/y) 25.5%
November 2025
- Nov 208-K8-K · Molina Healthcare Announces Closing of Offering of $850 Million of 6.500% Senior Notes Due 2031Material definitive agreement; New financial obligation; Other events
- Nov 188-K8-K · Molina Healthcare Announces Pricing of $850 Million of 6.500% Senior Notes Due 2031Regulation FD disclosure
- Nov 178-K8-K · Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2031Regulation FD disclosure
- Nov 148-K8-K · Molina Healthcare Awarded New Florida Medicaid ContractRegulation FD disclosure
October 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $3.5M in 3 sales and bought $100K in 1 purchase; 52 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| May 14, 2026Form 4 | HEBERT MAURICEChief Accounting OfficerSold · $115K · 600 sh |
| May 11, 2026Form 4 | Barlow Jeff D.Chief Legal OfficerSold · $3.3M · 17,811 sh |
| Mar 12, 2026Form 4 | ROMNEY RONNADirectorSold · $74K · 506 sh |
| Feb 11, 2026Form 4 | ZORETIC RICHARD CDirectorBought · $100K · 800 sh |
Awards, exercises, withholding and plan purchases · 52 transactions
| Date | Insider |
|---|---|
| Oct 1, 2026Form 4 | BRASIER BARBARA LDirectorAward · $55K · 304 sh |
| Oct 1, 2026Form 4 | ROMNEY RONNADirectorAward · $55K · 304 sh |
| Oct 1, 2026Form 4 | ORLANDO STEVEN JDirectorAward · $55K · 304 sh |
| Oct 1, 2026Form 4 | WOLF DALE BDirectorAward · $55K · 304 sh |
| Oct 1, 2026Form 4 | SOISTMAN FRANCIS S JRDirectorAward · $55K · 304 sh |
| Oct 1, 2026Form 4 | GROHOWSKI LEO PDirectorAward · $55K · 304 sh |
| Oct 1, 2026Form 4 | ZORETIC RICHARD CDirectorAward · $55K · 304 sh |
| Oct 1, 2026Form 4 | Schapiro Richard MDirectorAward · $55K · 304 sh |
| Oct 1, 2026Form 4 | Lockhart Stephen HDirectorAward · $55K · 304 sh |
| Jul 1, 2026Form 4 | BRASIER BARBARA LDirectorAward · $55K · 237 sh |
| Jul 1, 2026Form 4 | ROMNEY RONNADirectorAward · $55K · 237 sh |
| Jul 1, 2026Form 4 | ORLANDO STEVEN JDirectorAward · $55K · 237 sh |
| Jul 1, 2026Form 4 | WOLF DALE BDirectorAward · $55K · 237 sh |
| Jul 1, 2026Form 4 | SOISTMAN FRANCIS S JRDirectorAward · $55K · 237 sh |
| Jul 1, 2026Form 4 | GROHOWSKI LEO PDirectorAward · $55K · 237 sh |
| Jul 1, 2026Form 4 | ZORETIC RICHARD CDirectorAward · $55K · 237 sh |
| Jul 1, 2026Form 4 | Schapiro Richard MDirectorAward · $55K · 237 sh |
| Jul 1, 2026Form 4 | Lockhart Stephen HDirectorAward · $55K · 237 sh |
| Jul 1, 2026Form 4 | Bacon DebraEVP, MedicaidTax withholding · $43K · 183 sh |
| Jun 30, 2026Form 4 | WOYS JAMESChief Operating OfficerAward · $21K · 144 sh |
| Jun 30, 2026Form 4 | Barlow Jeff D.Chief Legal OfficerAward · $20K · 138 sh |
| Jun 30, 2026Form 4 | Bacon DebraEVP, MedicaidAward · $3,393 · 23 sh |
| May 6, 2026Form 4 | SOISTMAN FRANCIS S JRDirectorAward · $34K · 170 sh |
| Apr 1, 2026Form 4 | BRASIER BARBARA LDirectorAward · $55K · 405 sh |
| Apr 1, 2026Form 4 | ROMNEY RONNADirectorAward · $55K · 405 sh |
| Apr 1, 2026Form 4 | ORLANDO STEVEN JDirectorAward · $55K · 405 sh |
| Apr 1, 2026Form 4 | WOLF DALE BDirectorAward · $55K · 405 sh |
| Apr 1, 2026Form 4 | GROHOWSKI LEO PDirectorAward · $55K · 405 sh |
| Apr 1, 2026Form 4 | ZORETIC RICHARD CDirectorAward · $55K · 405 sh |
| Apr 1, 2026Form 4 | Schapiro Richard MDirectorAward · $55K · 405 sh |
| Apr 1, 2026Form 4 | Lockhart Stephen HDirectorAward · $55K · 405 sh |
| Mar 1, 2026Form 4 | Zubretsky Joseph MPresident & CEO · DirectorAward · $9.7M · 66,417 sh |
| Mar 1, 2026Form 4 | Keim Mark LowellChief Financial OfficerAward · $3.8M · 26,073 sh |
| Mar 1, 2026Form 4 | WOYS JAMESChief Operating OfficerAward · $2.5M · 17,016 sh |
| Mar 1, 2026Form 4 | Barlow Jeff D.Chief Legal OfficerAward · $2.0M · 13,722 sh |
| Mar 1, 2026Form 4 | Bacon DebraEVP, MedicaidAward · $1.4M · 9,606 sh |
| Mar 1, 2026Form 4 | Zubretsky Joseph MPresident & CEO · DirectorTax withholding · $1.3M · 8,597 sh |
| Mar 1, 2026Form 4 | HEBERT MAURICEChief Accounting OfficerAward · $400K · 2,708 sh |
| Mar 1, 2026Form 4 | Keim Mark LowellChief Financial OfficerTax withholding · $356K · 2,308 sh |
| Mar 1, 2026Form 4 | Barlow Jeff D.Chief Legal OfficerTax withholding · $252K · 1,638 sh |
| Mar 1, 2026Form 4 | WOYS JAMESChief Operating OfficerTax withholding · $202K · 1,313 sh |
| Mar 1, 2026Form 4 | Bacon DebraEVP, MedicaidTax withholding · $110K · 716 sh |
| Mar 1, 2026Form 4 | HEBERT MAURICEChief Accounting OfficerTax withholding · $77K · 501 sh |
| Jan 1, 2026Form 4 | BRASIER BARBARA LDirectorAward · $55K · 317 sh |
| Jan 1, 2026Form 4 | ROMNEY RONNADirectorAward · $55K · 317 sh |
| Jan 1, 2026Form 4 | ORLANDO STEVEN JDirectorAward · $55K · 317 sh |
| Jan 1, 2026Form 4 | WOLF DALE BDirectorAward · $55K · 317 sh |
| Jan 1, 2026Form 4 | GROHOWSKI LEO PDirectorAward · $55K · 317 sh |
| Jan 1, 2026Form 4 | ZORETIC RICHARD CDirectorAward · $55K · 317 sh |
| Jan 1, 2026Form 4 | Schapiro Richard MDirectorAward · $55K · 317 sh |
| Jan 1, 2026Form 4 | Lockhart Stephen HDirectorAward · $55K · 317 sh |
| Dec 31, 2025Form 4 | Bacon DebraEVP, MedicaidAward · $3,245 · 22 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 15 filings
| Filed | What it is |
|---|---|
| Jul 23, 202610-Q | Quarterly report, Q2 2026 — revenue $10.87B (−5% y/y), net income $60.0M, EPS $1.19 |
| Jul 22, 20268-K | Earnings release — EPS $1.51 vs $1.37 est. (+10.2%); revenue $10.87B (−5% y/y) 9.7% |
| Jun 10, 20268-K | Molina Healthcare Wins Illinois Medicaid ContractRegulation FD disclosure |
| May 11, 20268-K | Directors or officers; compensation; Charter, bylaws or fiscal-year change; Shareholder vote results |
| May 8, 20268-K | Regulation FD disclosure |
| Apr 23, 202610-Q | Quarterly report, Q1 2026 — revenue $10.80B (−3% y/y), net income $14.0M, EPS $0.27 |
| Apr 22, 20268-K | Earnings release — EPS $2.35 vs $1.57 est. (+49.7%); revenue $10.80B (−3% y/y) 14.2% |
| Mar 23, 2026ARS | Annual report to shareholders |
| Mar 23, 2026DEFA14A | Additional proxy materials |
| Mar 23, 2026DEF 14A | Proxy statement |
| Mar 13, 2026PRE 14A | Preliminary proxy statement |
| Feb 26, 20268-K | Regulation FD disclosure |
| Feb 10, 202610-K | Annual report, FY2025 — revenue $45.43B (+12% y/y), net income $472.0M, EPS $8.92 |
| Feb 6, 20268-K | Material definitive agreement; New financial obligation; Material impairment |
| Feb 5, 20268-K | Earnings release — EPS −$2.75 vs $0.43 est. (−739.5%); revenue $11.38B (+8% y/y) 25.5% |
2025 · 21 filings
| Filed | What it is |
|---|---|
| Nov 20, 20258-K | Molina Healthcare Announces Closing of Offering of $850 Million of 6.500% Senior Notes Due 2031Material definitive agreement; New financial obligation; Other events |
| Nov 18, 20258-K | Molina Healthcare Announces Pricing of $850 Million of 6.500% Senior Notes Due 2031Regulation FD disclosure |
| Nov 17, 20258-K | Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2031Regulation FD disclosure |
| Nov 14, 20258-K | Molina Healthcare Awarded New Florida Medicaid ContractRegulation FD disclosure |
| Oct 23, 202510-Q | Quarterly report, Q3 2025 — revenue $11.48B (+11% y/y), net income $79.0M, EPS $1.51 |
| Oct 22, 20258-K | Earnings release — EPS $1.84 vs $3.97 est. (−53.6%); revenue $11.48B (+11% y/y) 17.5% |
| Aug 12, 20258-K | Material definitive agreement; New financial obligation |
| Jul 24, 202510-Q | Quarterly report, Q2 2025 — revenue $11.43B (+16% y/y), net income $255.0M, EPS $4.75 |
| Jul 23, 20258-K | Earnings release — EPS $5.48 vs $5.50 est. (−0.4%); revenue $11.43B (+16% y/y) 16.8% |
| Jul 7, 20258-K | Results of operations |
| May 1, 20258-K | Directors or officers; compensation; Shareholder vote results |
| Apr 24, 202510-Q | Quarterly report, Q1 2025 — revenue $11.15B (+12% y/y), net income $298.0M, EPS $5.45 |
| Apr 23, 20258-K | Earnings release — EPS $6.08 vs $5.86 est. (+3.8%); revenue $11.15B (+12% y/y) 5.5% |
| Mar 18, 20258-K | Regulation FD disclosure |
| Mar 17, 2025ARS | Annual report to shareholders |
| Mar 17, 2025DEFA14A | Additional proxy materials |
| Mar 17, 2025DEF 14A | Proxy statement |
| Feb 21, 20258-K | Material definitive agreement; New financial obligation |
| Feb 11, 202510-K | Annual report, FY2024 — revenue $40.65B (+19% y/y), net income $1.18B, EPS $20.42 |
| Feb 5, 20258-K | Earnings release — EPS $5.05 vs $5.81 est. (−13.1%); revenue $10.50B (+16% y/y) 10.1% |
| Feb 3, 20258-K | Regulation FD disclosure |
2024 · 25 filings
| Filed | What it is |
|---|---|
| Dec 16, 20248-K | Regulation FD disclosure |
| Nov 18, 20248-K | Material definitive agreement; New financial obligation; Other events |
| Nov 13, 20248-K | Other events |
| Nov 13, 20248-K | Regulation FD disclosure; Other events |
| Nov 12, 20248-K | Other events |
| Nov 8, 20248-K | Regulation FD disclosure |
| Oct 24, 202410-Q | Quarterly report, Q3 2024 — revenue $10.34B (+21% y/y), net income $326.0M, EPS $5.65 |
| Oct 23, 20248-K | Earnings release — EPS $6.01 vs $5.96 est. (+0.8%); revenue $10.34B (+21% y/y) 17.7% |
| Oct 17, 20248-K | Directors or officers; compensation |
| Oct 16, 20248-K | Regulation FD disclosure |
| Sep 23, 20248-K | Material definitive agreement; New financial obligation |
| Aug 20, 20248-K | Directors or officers; compensation |
| Jul 25, 202410-Q | Quarterly report, Q2 2024 — revenue $9.88B (+19% y/y), net income $301.0M, EPS $5.17 |
| Jul 24, 20248-K | Earnings release — EPS $5.86 vs $5.73 est. (+2.3%); revenue $9.88B (+19% y/y) 12.3% |
| May 3, 20248-K | Shareholder vote results |
| Apr 25, 202410-Q | Quarterly report, Q1 2024 — revenue $9.93B (+22% y/y), net income $301.0M, EPS $5.17 |
| Apr 24, 20248-K | Earnings release — EPS $5.73 vs $5.46 est. (+5.0%); revenue $9.93B (+22% y/y) 4.1% |
| Apr 11, 20248-K | Regulation FD disclosure |
| Mar 21, 2024ARS | Annual report to shareholders |
| Mar 21, 2024DEFA14A | Additional proxy materials |
| Mar 21, 2024DEF 14A | Proxy statement |
| Feb 29, 20248-K | Regulation FD disclosure |
| Feb 13, 202410-K | Annual report, FY2023 — revenue $34.07B (+7% y/y), net income $1.09B, EPS $18.77 |
| Feb 7, 20248-K | Earnings release — EPS $4.38 vs $4.31 est. (+1.6%); revenue $9.05B (+10% y/y) 5.4% |
| Jan 2, 20248-K | Regulation FD disclosure |
2023 · 21 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Oct 26, 202310-Q | Quarterly report, Q3 2023 — revenue $8.55B (+8% y/y), net income $245.0M, EPS $4.21 |
| Jul 27, 202310-Q | Quarterly report, Q2 2023 — revenue $8.33B (+3% y/y), net income $309.0M, EPS $5.35 |
| Apr 27, 202310-Q | Quarterly report, Q1 2023 — revenue $8.15B (+5% y/y), net income $321.0M, EPS $5.52 |
| Mar 20, 2023DEFA14A | Additional proxy materials |
| Mar 20, 2023DEF 14A | Proxy statement |
| Feb 13, 202310-K | Annual report, FY2022 — revenue $31.97B (+15% y/y), net income $792.0M, EPS $13.55 |
15 current reports (8-K) not listed; the year is on EDGAR.
2022 · 21 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Oct 27, 202210-Q | Quarterly report, Q3 2022 — revenue $7.93B (+13% y/y), net income $230.0M, EPS $3.95 |
| Jul 28, 202210-Q | Quarterly report, Q2 2022 — revenue $8.05B (+18% y/y), net income $248.0M, EPS $4.25 |
| Apr 28, 202210-Q | Quarterly report, Q1 2022 — revenue $7.77B (+19% y/y), net income $258.0M, EPS $4.39 |
| Mar 23, 2022DEFA14A | Additional proxy materials |
| Mar 23, 2022DEF 14A | Proxy statement |
| Feb 14, 202210-K | Annual report, FY2021 — revenue $27.77B (+43% y/y), net income $659.0M, EPS $11.25 |
15 current reports (8-K) not listed; the year is on EDGAR.
2021 · 24 filings — 17 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Oct 28, 202110-Q | Quarterly report, Q3 2021 — revenue $7.04B (+40% y/y), net income $143.0M, EPS $2.46 |
| Jul 29, 202110-Q | Quarterly report, Q2 2021 — revenue $6.80B (+47% y/y), net income $185.0M, EPS $3.16 |
| Apr 29, 202110-Q | Quarterly report, Q1 2021 — revenue $6.52B (+43% y/y), net income $228.0M, EPS $3.89 |
| Mar 22, 2021DEFA14A | Additional proxy materials |
| Mar 22, 2021DEF 14A | Proxy statement |
| Feb 16, 202110-K | Annual report, FY2020 — revenue $19.42B (+15% y/y), net income $673.0M, EPS $11.23 |
18 current reports (8-K) not listed; the year is on EDGAR.
2020 · 30 filings — 24 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Oct 29, 202010-Q | Quarterly report, Q3 2020 — revenue $5.02B (+18% y/y), net income $185.0M, EPS $3.10 |
| Jul 31, 202010-Q | Quarterly report, Q2 2020 — revenue $4.62B (+10% y/y), net income $276.0M, EPS $4.65 |
| May 1, 202010-Q | Quarterly report, Q1 2020 — revenue $4.55B (+10% y/y), net income $178.0M, EPS $2.92 |
| Mar 24, 2020DEFA14A | Additional proxy materials |
| Mar 24, 2020DEF 14A | Proxy statement |
| Feb 14, 202010-K | Annual report, FY2019 — revenue $16.83B (−11% y/y), net income $737.0M, EPS $11.47 |
24 current reports (8-K) not listed; the year is on EDGAR.
2019 · 20 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Oct 30, 201910-Q | Quarterly report, Q3 2019 — revenue $4.24B (−10% y/y), net income $175.0M, EPS $2.75 |
| Jul 31, 201910-Q | Quarterly report, Q2 2019 — revenue $4.19B (−14% y/y), net income $196.0M, EPS $3.06 |
| Apr 30, 201910-Q | Quarterly report, Q1 2019 — revenue $4.12B (−11% y/y), net income $198.0M, EPS $2.99 |
| Mar 25, 2019DEFA14A | Additional proxy materials |
| Mar 25, 2019DEF 14A | Proxy statement |
| Mar 15, 2019PRE 14A | Preliminary proxy statement |
| Feb 19, 201910-K | Annual report, FY2018 — revenue $18.89B (−5% y/y), net income $707.0M, EPS $10.61 |
13 current reports (8-K) not listed; the year is on EDGAR.
2018 · 35 filings — 24 × 8-K, 3 × 10-Q, 3 × DEFA14A and 4 other forms
| Filed | What it is |
|---|---|
| Nov 1, 201810-Q | Quarterly report, Q3 2018 — revenue $4.70B (−7% y/y), net income $197.0M, EPS $2.90 |
| Aug 1, 201810-Q | Quarterly report, Q2 2018 — revenue $4.88B (−2% y/y), net income $202.0M, EPS $3.02 |
| Apr 30, 201810-Q | Quarterly report, Q1 2018 — revenue $4.65B (−5% y/y), net income $107.0M, EPS $1.64 |
| Apr 25, 2018DEFA14A | Additional proxy materials |
| Mar 19, 2018DEFA14A | Additional proxy materials |
| Mar 19, 2018DEF 14A | Proxy statement |
| Mar 9, 2018PRE 14A | Preliminary proxy statement |
| Mar 2, 2018DEFA14A | Additional proxy materials |
| Mar 1, 201810-K | Annual report, FY2017 — revenue $19.88B (+12% y/y), net income −$512.0M, EPS −$9.07 |
26 current reports (8-K) not listed; the year is on EDGAR.
2017 · 33 filings — 24 × 8-K, 3 × 10-Q, 2 × 8-K/A and 3 other forms
| Filed | What it is |
|---|---|
| Nov 7, 201710-Q | Quarterly report, Q3 2017 — revenue $5.03B (+11% y/y), net income −$97.0M, EPS −$1.70 |
| Aug 2, 201710-Q | Quarterly report, Q2 2017 — revenue $5.00B (+15% y/y), net income −$230.0M, EPS −$4.10 |
| May 4, 201710-Q | Quarterly report, Q1 2017 — revenue $4.90B (+13% y/y), net income $77.0M, EPS $1.37 |
| May 2, 2017DEFA14A | Additional proxy materials |
| Mar 13, 2017DEFA14A | Additional proxy materials |
| Mar 13, 2017DEF 14A | Proxy statement |
| Mar 1, 201710-K | Annual report, FY2016 — revenue $17.78B (+25% y/y), net income $52.0M, EPS $0.92 |
26 current reports (8-K) not listed; the year is on EDGAR.
2016 · 23 filings — 17 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2015 · 30 filings — 24 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2014 · 28 filings — 21 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2013 · 31 filings — 23 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2012 · 25 filings — 18 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2011 · 25 filings — 19 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2010 · 26 filings — 20 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2009 · 14 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2008 · 22 filings — 13 × 8-K, 3 × 10-Q, 2 × 10-Q/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2007 · 31 filings — 24 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2006 · 27 filings — 20 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2005 · 29 filings — 22 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2004 · 21 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2003 · 13 filings — 9 × 8-K, 2 × 10-Q, 1 × ARS and 1 other form
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 68 filings — 49 × 4, 9 × SCHEDULE 13G/A, 5 × SCHEDULE 13G and 3 other forms
| Filed | What it is |
|---|---|
| Oct 2, 20264 | Insider transaction (Form 4) |
| Oct 2, 20264 | Insider transaction (Form 4) |
| Oct 2, 20264 | Insider transaction (Form 4) |
| Oct 2, 20264 | Insider transaction (Form 4) |
| Oct 2, 20264 | Insider transaction (Form 4) |
| Oct 2, 20264 | Insider transaction (Form 4) |
| Oct 2, 20264 | Insider transaction (Form 4) |
| Oct 2, 20264 | Insider transaction (Form 4) |
| Oct 2, 20264 | Insider transaction (Form 4) |
| Sep 3, 2026SCHEDULE 13G | Other filings |
| Aug 13, 2026SCHEDULE 13G/A | Other filings |
| Aug 12, 2026SCHEDULE 13G/A | Other filings |
| Aug 6, 2026SCHEDULE 13G/A | Other filings |
| Jul 2, 20264 | Insider transaction (Form 4) |
| Jul 2, 20264 | Insider transaction (Form 4) |
| Jul 2, 20264 | Insider transaction (Form 4) |
| Jul 2, 20264 | Insider transaction (Form 4) |
| Jul 2, 20264 | Insider transaction (Form 4) |
| Jul 2, 20264 | Insider transaction (Form 4) |
| Jul 2, 20264 | Insider transaction (Form 4) |
| Jul 2, 20264 | Insider transaction (Form 4) |
| Jul 2, 20264 | Insider transaction (Form 4) |
| Jul 2, 20264 | Insider transaction (Form 4) |
| Jul 2, 20264 | Insider transaction (Form 4) |
| Jul 2, 20264 | Insider transaction (Form 4) |
The newest 25 of 68 shown; the full year is on EDGAR.
2025 · 67 filings — 51 × 4, 7 × 144, 3 × SCHEDULE 13G and 4 other forms
| Filed | What it is |
|---|---|
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 2025144 | Notice of proposed sale (Form 144) |
| Nov 14, 2025SCHEDULE 13G | Other filings |
| Nov 14, 2025SCHEDULE 13G | Other filings |
| Oct 2, 20254 | Insider transaction (Form 4) |
| Oct 2, 20254 | Insider transaction (Form 4) |
| Oct 2, 20254 | Insider transaction (Form 4) |
| Oct 2, 20254 | Insider transaction (Form 4) |
| Oct 2, 20254 | Insider transaction (Form 4) |
| Oct 2, 20254 | Insider transaction (Form 4) |
| Oct 2, 20254 | Insider transaction (Form 4) |
| Oct 2, 20254 | Insider transaction (Form 4) |
| Aug 14, 2025SCHEDULE 13G/A | Other filings |
| Aug 13, 2025SCHEDULE 13G/A | Other filings |
| Aug 8, 20254 | Insider transaction (Form 4) |
| Aug 6, 20254 | Insider transaction (Form 4) |
| Aug 4, 2025144 | Notice of proposed sale (Form 144) |
| Jul 2, 20254 | Insider transaction (Form 4) |
| Jul 2, 20254 | Insider transaction (Form 4) |
| Jul 2, 20254 | Insider transaction (Form 4) |
| Jul 2, 20254 | Insider transaction (Form 4) |
| Jul 2, 20254 | Insider transaction (Form 4) |
| Jul 2, 20254 | Insider transaction (Form 4) |
| Jul 2, 20254 | Insider transaction (Form 4) |
| Jul 2, 20254 | Insider transaction (Form 4) |
The newest 25 of 67 shown; the full year is on EDGAR.
2024 · 76 filings — 53 × 4, 13 × 144, 6 × SC 13G/A and 2 other forms
| Filed | What it is |
|---|---|
| Nov 19, 20244 | Insider transaction (Form 4) |
| Nov 14, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 12, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Nov 8, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Oct 28, 2024144 | Notice of proposed sale (Form 144) |
| Oct 28, 2024144 | Notice of proposed sale (Form 144) |
| Oct 2, 20244 | Insider transaction (Form 4) |
| Oct 2, 20244 | Insider transaction (Form 4) |
| Oct 2, 20244 | Insider transaction (Form 4) |
| Oct 2, 20244 | Insider transaction (Form 4) |
| Oct 2, 20244 | Insider transaction (Form 4) |
| Oct 2, 20244 | Insider transaction (Form 4) |
| Oct 2, 20244 | Insider transaction (Form 4) |
| Oct 2, 20244 | Insider transaction (Form 4) |
| Aug 16, 20244 | Insider transaction (Form 4) |
| Aug 15, 2024144 | Notice of proposed sale (Form 144) |
| Jul 30, 20244 | Insider transaction (Form 4) |
| Jul 30, 20244 | Insider transaction (Form 4) |
| Jul 29, 2024144 | Notice of proposed sale (Form 144) |
| Jul 29, 2024144 | Notice of proposed sale (Form 144) |
| Jul 2, 20244 | Insider transaction (Form 4) |
| Jul 2, 20244 | Insider transaction (Form 4) |
| Jul 2, 20244 | Insider transaction (Form 4) |
| Jul 2, 20244 | Insider transaction (Form 4) |
| Jul 2, 20244 | Insider transaction (Form 4) |
The newest 25 of 76 shown; the full year is on EDGAR.
2023 · 64 filings — 50 × 4, 8 × 144, 5 × SC 13G/A and 1 other form
Counted, not listed; the year is on EDGAR.
2022 · 80 filings — 72 × 4, 6 × SC 13G/A, 1 × CT ORDER and 1 other form
Counted, not listed; the year is on EDGAR.
2021 · 65 filings — 57 × 4, 6 × SC 13G/A, 1 × 3 and 1 other form
Counted, not listed; the year is on EDGAR.
2020 · 69 filings — 59 × 4, 9 × SC 13G/A, 1 × 3
Counted, not listed; the year is on EDGAR.
2019 · 75 filings — 59 × 4, 4 × SC 13G, 4 × SC 13G/A and 6 other forms
Counted, not listed; the year is on EDGAR.
2018 · 97 filings — 81 × 4, 6 × 3, 4 × SC 13G/A and 6 other forms
Counted, not listed; the year is on EDGAR.
2017 · 148 filings — 137 × 4, 4 × SC 13G, 2 × SC 13G/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2016 · 107 filings — 89 × 4, 6 × SC 13G, 2 × CORRESP and 7 other forms
Counted, not listed; the year is on EDGAR.
2015 · 136 filings — 114 × 4, 6 × CORRESP, 6 × SC 13G and 5 other forms
Counted, not listed; the year is on EDGAR.
2014 · 89 filings — 78 × 4, 6 × SC 13G, 1 × 3 and 4 other forms
Counted, not listed; the year is on EDGAR.
2013 · 78 filings — 66 × 4, 6 × SC 13G, 3 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2012 · 84 filings — 56 × 4, 8 × SC 13G, 6 × CORRESP and 5 other forms
Counted, not listed; the year is on EDGAR.
2011 · 59 filings — 42 × 4, 6 × SC 13G, 3 × 4/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2010 · 88 filings — 71 × 4, 6 × SC 13G, 3 × SC 13G/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2009 · 79 filings — 70 × 4, 3 × SC 13G, 3 × SC 13G/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2008 · 129 filings — 96 × 4, 10 × SC 13G, 7 × 4/A and 8 other forms
Counted, not listed; the year is on EDGAR.
2007 · 124 filings — 109 × 4, 5 × 3, 3 × 4/A and 7 other forms
Counted, not listed; the year is on EDGAR.
2006 · 109 filings — 102 × 4, 4 × 4/A, 1 × 3 and 2 other forms
Counted, not listed; the year is on EDGAR.
2005 · 73 filings — 56 × 4, 6 × 3, 6 × 4/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2004 · 90 filings — 74 × 4, 7 × SC 13G, 3 × 3 and 6 other forms
Counted, not listed; the year is on EDGAR.
2003 · 29 filings — 17 × 4, 7 × S-1/A, 1 × 424B4 and 4 other forms
Counted, not listed; the year is on EDGAR.
2002 · 1 filing — 1 × S-1
Counted, not listed; the year is on EDGAR.
About this data#
Molina Healthcare Inc (MOH) has 2,674 filings on EDGAR going back to 2002: 24 annual reports, 72 quarterly reports and 438 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 10, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Jul 22, 2026, furnished a press release headed “Molina Healthcare Reports Second Quarter 2026 Financial Results”. Over the last 13 months insiders sold $3.5M in 3 sales and bought $100K in 1 purchase; 52 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Molina Healthcare Inc, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read MOH's latest 10-K?
- MOH's latest annual report, a 10-K, was filed on Feb 10, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did MOH last file an 8-K?
- On Jul 22, 2026 it furnished a press release headed “Molina Healthcare Reports Second Quarter 2026 Financial Results”. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Jul 22, 2026.
- Are MOH insiders buying or selling?
- Over the last 13 months insiders sold $3.5M in 3 sales and bought $100K in 1 purchase; 52 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: HEBERT MAURICE (Chief Accounting Officer) sold 600 shares on May 14, 2026 for $115K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has MOH made?
- 2,674 filings are on EDGAR under the registrant records that have been Molina Healthcare Inc, going back to 2002; 1,814 of them are insider ownership forms (Forms 3, 4, 5 and 144).